middle.news
CURE’s biotech rebound delivers a AUD22.6m profit
4:06pm on Friday 25th of September, 2026 AEST
•
Financial Services
Read Story
CURE’s biotech rebound delivers a AUD22.6m profit
4:06pm on Friday 25th of September, 2026 AEST
Key Points
AUD22.601 million profit versus prior-year loss of AUD2.863 million
AUD22.742 million in net fair-value and foreign exchange gains
Net assets rose to AUD51.661 million from AUD29.453 million
No distribution was paid or payable for the year
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
GLOBAL X S&P BIOTECH ETF (ASX:CUR)
OPEN ARTICLE